
<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Brittany+deRonde</id>
	<title>Proteopedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Brittany+deRonde"/>
	<link rel="alternate" type="text/html" href="https://proteopedia.org/Special:Contributions/Brittany_deRonde"/>
	<updated>2026-10-06T01:13:49Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876416</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876416"/>
		<updated>2013-12-17T19:25:32Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt; The protein is modeled here &amp;lt;scene name=&#039;47/477029/Hiv_tat3/3&#039;&amp;gt;as a cartoon&amp;lt;/scene&amp;gt; to highlight the lack of an alpha helix or a beta sheet. TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Proteins that contain protein transduction domains. When the background is black, the protein modeled is HIV-1 TAT and when the background is white, the protein modeled is Antennapedia.&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; The protein is modeled such that &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt; are pink and &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt; are grey. It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein &amp;lt;scene name=&#039;47/477029/Antennapedia/1&#039;&amp;gt;(model of antennapedia)&amp;lt;/scene&amp;gt;, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876415</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876415"/>
		<updated>2013-12-17T19:23:16Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt; The protein is modeled here &amp;lt;scene name=&#039;47/477029/Hiv_tat3/3&#039;&amp;gt;as a cartoon&amp;lt;/scene&amp;gt; to highlight the lack of an alpha helix or a beta sheet. TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Proteins that contain protein transduction domains.&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; The protein is modeled such that &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt; are pink and &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt; are grey. It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein &amp;lt;scene name=&#039;47/477029/Antennapedia/1&#039;&amp;gt;(model of antennapedia)&amp;lt;/scene&amp;gt;, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876414</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876414"/>
		<updated>2013-12-17T19:05:48Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt; The protein is modeled here &amp;lt;scene name=&#039;47/477029/Hiv_tat3/3&#039;&amp;gt;as a cartoon&amp;lt;/scene&amp;gt; to highlight the lack of an alpha helix or a beta sheet. TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT: Transactivator of Transcription&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; The protein is modeled such that &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt; are pink and &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt; are grey. It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876413</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876413"/>
		<updated>2013-12-17T19:04:35Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt; The protein is modeled here to highlight the lack of an alpha helix or a beta sheet. &amp;lt;scene name=&#039;47/477029/Hiv_tat3/3&#039;&amp;gt;as a Cartoon.&amp;lt;/scene&amp;gt; TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT: Transactivator of Transcription&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; The protein is modeled such that &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt; are pink and &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt; are grey. It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876412</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1876412"/>
		<updated>2013-12-17T19:02:47Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt; The protein is modeled &amp;lt;scene name=&#039;47/477029/Hiv_tat3/3&#039;&amp;gt;as a Cartoon.&amp;lt;/scene&amp;gt; TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT: Transactivator of Transcription&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; The protein is modeled such that &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt; are pink and &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt; are grey. It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1873891</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1873891"/>
		<updated>2013-12-09T15:51:45Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
Fall 2013: CBI Molecules are due 12/4/13 and should be added at the TOP of the list from your lab. Label it as &amp;quot;in progress&amp;quot; until you are finished, and then as &amp;quot;New 2013&amp;quot; or &amp;quot;Revised 2013&amp;quot;. For those editing an existing CBI Molecule, start from that entry so that it retains the full author list of all authors that contributed (or include credits to the original page and authors if it does not).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
&#039;&#039;&#039;** Designates CBI Molecules Featured on [http://http://www.umass.edu/cbi/ CBI website]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2010]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~chenlab/index.HTML Chen Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2012!! &#039;&#039;&#039;[[Molecular Playground/OmpG]]&#039;&#039;&#039;, Christina Chisholm&lt;br /&gt;
: New Fall 2013!! &#039;&#039;&#039;[[Molecular Playground/ClyA]]&#039;&#039;&#039;, Bib Yang&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
New Fall 2013! : **&#039;&#039;&#039;[[Molecular Playground/Homo-dimeric RcdA]]&#039;&#039;&#039;, Kamal K. Joshi &lt;br /&gt;
&lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/DNA replication initiator DnaA]]&#039;&#039;&#039;, Jing Liu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy&lt;br /&gt;
:: Best Overall CBI Molecule 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CRABP I (Cellular Retinoic Acid Binding Protein)]]&#039;&#039;&#039;, Gustavo Elberto Epalza Sanchez&lt;br /&gt;
(compare this to the previous version above to see what&#039;s new)&lt;br /&gt;
&lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &lt;br /&gt;
:: Best CBI Molecule 2012&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2013!! &#039;&#039;&#039;[[Molecular Playground/Executioner Caspase-7]]&#039;&#039;&#039;, Derek MacPherson, Maureen E. Hill&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/[[Caspase-3 Regulatory Mechanisms]]&#039;&#039;&#039;, Scott Eron, Bay Serrano, Yunlong Zhao&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[Molecular Playground/Caspase-6 and neurodegeneration]]&#039;&#039;&#039;, Kevin Buadlart Dagbay&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: New Fall 2013!! &#039;&#039;&#039;[[Molecular_Playground/Hsp70-Hsp90]]&#039;&#039;&#039;,  Jill Graham&lt;br /&gt;
: New Fall 2012!! &#039;&#039;&#039;[[Molecular_Playground/ERDj5]]&#039;&#039;&#039;,  Lydia Lamriben&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: Updated Fall 2012!! &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano, Carolina Morell-Pérez&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mholden/ Holden Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2012!! &#039;&#039;&#039;[[Molecular Playground/Protective Antigen]]&#039;&#039;&#039;,  Jing Huang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
New 2013! &#039;&#039;&#039;[http://proteopedia.org/wiki/index.php/Chengfeng_Ren Molecular Playground/Inteferon]&#039;&#039;&#039;, Chengfeng Ren&lt;br /&gt;
&lt;br /&gt;
: Updated Fall 2012!! &#039;&#039;&#039; [[Molecular Playground/Transferrin]]&#039;&#039;&#039;, Khaja Muneeruddin, Jake Pawlowski&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Knapp lab&lt;br /&gt;
&lt;br /&gt;
: Updated Fall 2013!! &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;, Vanessa Chaplin, Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
 &lt;br /&gt;
: Updated Fall 2012!! &#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin, Serap Pektas&lt;br /&gt;
:: Best CBI Molecule Proteopedia Page 2010&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mmaroney/ Maroney Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Nickel Superoxide Dismutase]]&#039;&#039;&#039;, Carolyn Carr&lt;br /&gt;
: Updated Fall 2013!!  &#039;&#039;&#039;[[Molecular Playground/CsoR and RcnR]]&#039;&#039;&#039;, Heidi Hu, Carolyn Carr&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/HypA]]&#039;&#039;&#039;, Heidi Hu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.peytonlab.org/ Peyton Lab]&lt;br /&gt;
: New Fall 2013! &#039;&#039;&#039;[[Molecular Playground/MMP14]]&#039;&#039;&#039;, Lauren Jansen&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FAK]]&#039;&#039;&#039;, Dannielle Ryman&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
[http://http://www.umass.edu/schiffman/  Schiffman Lab]&lt;br /&gt;
:New Fall 2013! &#039;&#039;&#039;[[Molecular Playground/Streptavidin]]&#039;&#039;&#039;, Katrina Rieger&lt;br /&gt;
&lt;br /&gt;
[https://elements.chem.umass.edu/schnarrlab/ Schnarr Lab] &lt;br /&gt;
&lt;br /&gt;
: New Fall 2012!! &#039;&#039;&#039;[[Molecular Playground/4&#039;-PHOSPHOPANTETHEINYL TRANSFERASE (Sfp)]]&#039;&#039;&#039;, Jon Amoroso, Gitanjeli Prasad, Lawrence Sheringham Borketey &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso, Lawrence Sheringham Borketey&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/faculty/danny-j-schnell Schnell Lab]&lt;br /&gt;
: New Fall 2012!! &#039;&#039;&#039;[[Molecular Playground/Tic40]]&#039;&#039;&#039;, Mine Canakci&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: Updated Fall 2013!!  &#039;&#039;&#039;[[Molecular Playground/HIV Tat]]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
: New Fall 2013!! &#039;&#039;&#039;[[Interleukin-1 beta]]&#039;&#039;&#039;, Huan He&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson] &amp;amp; [http://www.chem.umass.edu/~rmweis/weislab/ Weis] Labs&lt;br /&gt;
&lt;br /&gt;
: New Fall 2012!! &#039;&#039;&#039;[[Molecular Playground/CheA]]&#039;&#039;&#039;, Elizabeth R. Haglin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2013!! &#039;&#039;&#039;[[Molecular Playground/Human Serum Albumin]]&#039;&#039;&#039;, Mahalia Serrano&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto&lt;br /&gt;
:: Best CBI Molecule Jmol scenes 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Ubiquitin salt bridge discussion]]&#039;&#039;&#039;, Zhe Zhang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;The goal is for students to work collaboratively to create one excellent CBI Molecule for each CBI research group, to be featured on the CBI website.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2013: Complete steps 1-2 by 10/18, and bring your computer to the CBI Molecule Workshop on Wed 10/23 in ISB 321. &lt;br /&gt;
&lt;br /&gt;
A successful CBI Molecule will be an interesting, nontechnical description of a molecule related to your group&#039;s research. It should not be super long, but instead have multiple green scenes. Green scenes should clearly show an interesting feature and should be attractive. Use the green scenes to help you make interesting points about the molecule (do not try to describe every feature of the molecule). It&#039;s great if you can end with a brief statement about how it relates to your group&#039;s research goals.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. &lt;br /&gt;
&lt;br /&gt;
2. Read through the rest of the instructions and look at any existing CBI Molecules from your research group. Talk with other Chalk Talk students in your research group and think about how you can make a new or improved CBI Molecule related to your group&#039;s research. Develop ideas for the scenes you wish to show. You will work learn how to make scenes during the workshop. &lt;br /&gt;
&lt;br /&gt;
3. Get started working in Proteopedia by using the links at [[Help:Contents]]. Make yourself a sandbox page: Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. Practice entering text, inserting a structure window with scrolling text (green 4-square button on the right), and creating a green scene. You can look at other Proteopedia pages in edit mode to see how different effects (like colored text) are achieved (but this won&#039;t show you how the scene effects are made). &lt;br /&gt;
&lt;br /&gt;
4. For those editing an existing CBI Molecule, start from that entry so that it retains the full author list of all authors that contributed. You are encouraged to collaborate on the CBI Molecules, but everyone will need to do some editing of the molecule so that they each appear as authors on the final list. If you are the sole student from your group enrolled in Chalk Talk and have not previously made a CBI Molecule, try to convince another group member who has previously made a CBI Molecule (see  list above) to join us for the workshop so that you can work together.&lt;br /&gt;
&lt;br /&gt;
5. Your final pages should be called &amp;quot;Molecular Playground/your molecule&amp;quot; and should have links on this CBI Molecule page -- put the new ones first on the list from your research group. Label them &amp;quot;in progress&amp;quot; until you are finished, and then &amp;quot;new 2013&amp;quot; or &amp;quot;revised 2013&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Overview at [[Help:Contents ]]&lt;br /&gt;
&lt;br /&gt;
See also [[Help:Getting_Started_in_Proteopedia]] &lt;br /&gt;
&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543752</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543752"/>
		<updated>2012-10-12T03:23:45Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT: Transactivator of Transcription&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; The protein is modeled such that &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt; are pink and &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt; are grey. It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543751</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543751"/>
		<updated>2012-10-12T03:23:06Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT: Transactivator of Transcription&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; The protein is modeled such that &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt; are pink and &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt;) are grey. It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543750</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543750"/>
		<updated>2012-10-12T03:17:03Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543749</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543749"/>
		<updated>2012-10-12T03:16:24Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt; &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt;, and &amp;lt;font color=&#039;blue&#039;&amp;gt;protein transduction domain &amp;lt;/font&amp;gt;(blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543748</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543748"/>
		<updated>2012-10-12T03:15:04Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT. &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt;, and &amp;lt;font color=&#039;blue&#039;&amp;gt;protein transduction domain &amp;lt;/font&amp;gt;(blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543747</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543747"/>
		<updated>2012-10-12T03:12:07Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT. &amp;lt;font color=&#039;grey&#039;&amp;gt;polar residues &amp;lt;/font&amp;gt;, &amp;lt;font color=&#039;pink&#039;&amp;gt;hydrophobic residues &amp;lt;/font&amp;gt;, and &amp;lt;font color=&#039;blue&#039;&amp;gt;protein transduction domain &amp;lt;/font&amp;gt;(blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543584</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543584"/>
		<updated>2012-10-10T17:38:23Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Cell Penetrating Peptides&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543579</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543579"/>
		<updated>2012-10-10T17:31:05Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Cell Penetrating Peptides&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The &amp;lt;font color=&#039;light blue&#039;&amp;gt;PTD &amp;lt;/font&amp;gt; is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues. (&amp;lt;font color=&#039;red&#039;&amp;gt;Arginine &amp;lt;/font&amp;gt;&amp;lt;/scene&amp;gt; and &amp;lt;font color=&#039;green&#039;&amp;gt;Lysine &amp;lt;/font&amp;gt;) This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543564</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543564"/>
		<updated>2012-10-10T17:20:11Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Cell Penetrating Peptides&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The PTD is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543563</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543563"/>
		<updated>2012-10-10T17:19:07Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;). The PTD is rich in &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues.&amp;lt;/scene&amp;gt; This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT. Specifically, the &amp;lt;scene name=&#039;Molecular_Playground/HIV_Tat/Hiv_tat2/1&#039;&amp;gt;Arginine and Lysine residues&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543535</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1543535"/>
		<updated>2012-10-10T16:53:52Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV-1 TAT&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  TAT, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV TAT. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of TAT have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in HIV TAT is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV TAT.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV TAT, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;TAT-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV TAT is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV TAT primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of TAT in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of TAT-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
==3D structures of Tat protein==&lt;br /&gt;
&lt;br /&gt;
[[Tat protein]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Oligomer.pdb&amp;diff=1341832</id>
		<title>File:Oligomer.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Oligomer.pdb&amp;diff=1341832"/>
		<updated>2012-01-12T04:55:00Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: uploaded a new version of &amp;quot;Image:Oligomer.pdb&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Oligomer.mol&amp;diff=1341831</id>
		<title>File:Oligomer.mol</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Oligomer.mol&amp;diff=1341831"/>
		<updated>2012-01-12T04:54:24Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Oligomer.pdb&amp;diff=1341830</id>
		<title>File:Oligomer.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Oligomer.pdb&amp;diff=1341830"/>
		<updated>2012-01-12T04:46:05Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:XXX1.mol&amp;diff=1341829</id>
		<title>File:XXX1.mol</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:XXX1.mol&amp;diff=1341829"/>
		<updated>2012-01-12T03:57:36Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:XXX.mol&amp;diff=1341828</id>
		<title>File:XXX.mol</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:XXX.mol&amp;diff=1341828"/>
		<updated>2012-01-12T03:48:59Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333715</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333715"/>
		<updated>2011-12-23T23:22:34Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Cell Penetrating Peptides&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in HIV Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333714</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333714"/>
		<updated>2011-12-23T23:17:24Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Cell Penetrating Peptides&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargoes can be associated with CPPs via covalent or non-covalent interactions.  HIV Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Arginine and/or Lysine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in HIV Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has been shown to have improved cellular uptake compared to HIV Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
ARGININE-RICH SEQUENCES KNOWN TO TRANSLOCATE EFFICIENTLY&lt;br /&gt;
----&lt;br /&gt;
HIV-Tat        RKKRRQRRR&lt;br /&gt;
Penetratin     RQIKIWFQNRRMKWKK&lt;br /&gt;
SAP            VRLPPPVRLPPPVRLPPP&lt;br /&gt;
HIV-1 Rev      TRQARRNRRRRWRERQR&lt;br /&gt;
FHV            RRRRNRTRRNRRRVR&lt;br /&gt;
HTLV-II        TRRQRTRRARRNR&lt;br /&gt;
NLS            KRPAAIKKAGQAKKKK&lt;br /&gt;
Transportan    GWTLNSAGYLLGKINLKALAALAKKIL&lt;br /&gt;
pVEC           LLIILRRRIRKQAHAHSK&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333713</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333713"/>
		<updated>2011-12-23T23:03:57Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain (blue color appears when you click the green link)&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333712</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333712"/>
		<updated>2011-12-23T22:53:57Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333710</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333710"/>
		<updated>2011-12-23T21:46:37Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
It&#039;s great to build on a previous entry, but you must leave the earlier one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
Fall 2011: New entries are due 12/16/11. Please append the designation (new Fall 2011) to your new entries. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2010]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy&lt;br /&gt;
:: Best Overall CBI Molecule 2010&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Caspase-6 and neurodegeneration]]&#039;&#039;&#039;, Kevin Buadlart Dagbay&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Transferrin]]&#039;&#039;&#039;, Khaja Muneeruddin&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Knapp lab&lt;br /&gt;
 &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin&lt;br /&gt;
:: Best CBI Molecule Proteopedia Page 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;,  Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mmaroney/ Maroney Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011!! &#039;&#039;&#039;[[Molecular Playground/CsoR and RcnR]]&#039;&#039;&#039;, Heidi Hu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
Peyton Lab&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/FAK]]&#039;&#039;&#039;, Dannielle Ryman&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
Schnarr Lab &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: NEW FALL 2011!! &#039;&#039;&#039;[[Molecular Playground/HIV Tat]]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson] &amp;amp; [http://www.chem.umass.edu/~rmweis/weislab/ Weis] Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011 &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto&lt;br /&gt;
:: Best CBI Molecule Jmol scenes 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Congratulations to the prize-winning CBI molecules noted above! These also provide great examples to follow. Another prize for best CBI Molecule page and/or scene will be awarded in summer 2012!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2011: Complete steps 1-4 by 12/1/11, in preparation for the CBI Molecule Workshop.&lt;br /&gt;
&lt;br /&gt;
Choose a molecule that is part of your research project. If someone in your group has already made a page for your research molecule, you can improve on that previous entry. You must leave the previously created page intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. If you are new to Proteopedia, click Help in the navigation box on the left to get started.&lt;br /&gt;
&lt;br /&gt;
2. Make yourself a sandbox page in which you will develop your CBI Molecule scene and description  (Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. See example [[User:Lynmarie K Thompson/Sandbox 1]]). &lt;br /&gt;
&lt;br /&gt;
3. Follow the format of the sample CBI molecule page [[Molecular Playground/Bacterial Chemotaxis Receptors]]. Easiest way to do this is to copy this page (in editing mode), paste it into your sandbox page, keep the first paragraph about CBI molecules, and then edit to describe and display your molecule. Your goal is to make this an interesting, nontechnical description of the molecule. If multiple people in one group work on the same molecule, you can each make different scenes for the same CBI molecule and each describe them on the same proteopedia page. Talk with each other about your plans so you are not duplicating efforts.&lt;br /&gt;
&lt;br /&gt;
4. Add a link to your sandbox page at [[Sandbox_CBI]] (CBI Molecules in Progress).&lt;br /&gt;
&lt;br /&gt;
5. Create an attractive scene for your molecule: use the scene authoring tools in the edit mode to create the view you like, then copy the wiki text into your window.&lt;br /&gt;
&lt;br /&gt;
6. Choose a &amp;quot;green scene&amp;quot; on your Proteopedia page to suggest for display at the Molecular Playground and specify a &amp;quot;banner&amp;quot; which will be projected with the molecule. This should be a short, one-line headline for your scene that includes the name of the molecule and what is important about the scene or the molecule. Remember to design this for the general public, including non-scientists. My example is: &amp;quot;Molecular Playground banner: A bacterial chemotaxis receptor protein used by bacteria to &amp;quot;smell&amp;quot; their environment.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
7. When you are happy with your sandbox page, make yourself a permanent Proteopedia page, which will be editable by others. Enter &amp;quot;Molecular Playground/your molecule&amp;quot; (omit quotes) in the search box, then follow the instructions to create a new page with this title. Copy the content of your sandbox to this new page.&lt;br /&gt;
&lt;br /&gt;
8. When you have finished the final version of your page and scene, edit this CBI Molecules page to add a listing and link for your molecule, following the  examples above, and be sure to mark it as NEW FALL 2011. If you are improving a previously created page, leave the old one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list. When multiple authors contribute to a Molecular Playground page, please indicate your scene with your initials. Please link the lab names to web pages too.&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333709</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333709"/>
		<updated>2011-12-23T21:45:39Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
It&#039;s great to build on a previous entry, but you must leave the earlier one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
Fall 2011: New entries are due 12/16/11. Please append the designation (new Fall 2011) to your new entries. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2010]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy&lt;br /&gt;
:: Best Overall CBI Molecule 2010&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Caspase-6 and neurodegeneration]]&#039;&#039;&#039;, Kevin Buadlart Dagbay&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Transferrin]]&#039;&#039;&#039;, Khaja Muneeruddin&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Knapp lab&lt;br /&gt;
 &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin&lt;br /&gt;
:: Best CBI Molecule Proteopedia Page 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;,  Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mmaroney/ Maroney Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011!! &#039;&#039;&#039;[[Molecular Playground/CsoR and RcnR]]&#039;&#039;&#039;, Heidi Hu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
Peyton Lab&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/FAK]]&#039;&#039;&#039;, Dannielle Ryman&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
Schnarr Lab &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: NEW FALL 2011!! &#039;&#039;&#039;[[Molecular Playground_HIV Tat]]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson] &amp;amp; [http://www.chem.umass.edu/~rmweis/weislab/ Weis] Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011 &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto&lt;br /&gt;
:: Best CBI Molecule Jmol scenes 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Congratulations to the prize-winning CBI molecules noted above! These also provide great examples to follow. Another prize for best CBI Molecule page and/or scene will be awarded in summer 2012!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2011: Complete steps 1-4 by 12/1/11, in preparation for the CBI Molecule Workshop.&lt;br /&gt;
&lt;br /&gt;
Choose a molecule that is part of your research project. If someone in your group has already made a page for your research molecule, you can improve on that previous entry. You must leave the previously created page intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. If you are new to Proteopedia, click Help in the navigation box on the left to get started.&lt;br /&gt;
&lt;br /&gt;
2. Make yourself a sandbox page in which you will develop your CBI Molecule scene and description  (Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. See example [[User:Lynmarie K Thompson/Sandbox 1]]). &lt;br /&gt;
&lt;br /&gt;
3. Follow the format of the sample CBI molecule page [[Molecular Playground/Bacterial Chemotaxis Receptors]]. Easiest way to do this is to copy this page (in editing mode), paste it into your sandbox page, keep the first paragraph about CBI molecules, and then edit to describe and display your molecule. Your goal is to make this an interesting, nontechnical description of the molecule. If multiple people in one group work on the same molecule, you can each make different scenes for the same CBI molecule and each describe them on the same proteopedia page. Talk with each other about your plans so you are not duplicating efforts.&lt;br /&gt;
&lt;br /&gt;
4. Add a link to your sandbox page at [[Sandbox_CBI]] (CBI Molecules in Progress).&lt;br /&gt;
&lt;br /&gt;
5. Create an attractive scene for your molecule: use the scene authoring tools in the edit mode to create the view you like, then copy the wiki text into your window.&lt;br /&gt;
&lt;br /&gt;
6. Choose a &amp;quot;green scene&amp;quot; on your Proteopedia page to suggest for display at the Molecular Playground and specify a &amp;quot;banner&amp;quot; which will be projected with the molecule. This should be a short, one-line headline for your scene that includes the name of the molecule and what is important about the scene or the molecule. Remember to design this for the general public, including non-scientists. My example is: &amp;quot;Molecular Playground banner: A bacterial chemotaxis receptor protein used by bacteria to &amp;quot;smell&amp;quot; their environment.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
7. When you are happy with your sandbox page, make yourself a permanent Proteopedia page, which will be editable by others. Enter &amp;quot;Molecular Playground/your molecule&amp;quot; (omit quotes) in the search box, then follow the instructions to create a new page with this title. Copy the content of your sandbox to this new page.&lt;br /&gt;
&lt;br /&gt;
8. When you have finished the final version of your page and scene, edit this CBI Molecules page to add a listing and link for your molecule, following the  examples above, and be sure to mark it as NEW FALL 2011. If you are improving a previously created page, leave the old one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list. When multiple authors contribute to a Molecular Playground page, please indicate your scene with your initials. Please link the lab names to web pages too.&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333705</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333705"/>
		<updated>2011-12-23T21:25:09Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
It&#039;s great to build on a previous entry, but you must leave the earlier one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
Fall 2011: New entries are due 12/16/11. Please append the designation (new Fall 2011) to your new entries. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2010]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy&lt;br /&gt;
:: Best Overall CBI Molecule 2010&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Caspase-6 and neurodegeneration]]&#039;&#039;&#039;, Kevin Buadlart Dagbay&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Transferrin]]&#039;&#039;&#039;, Khaja Muneeruddin&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Knapp lab&lt;br /&gt;
 &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin&lt;br /&gt;
:: Best CBI Molecule Proteopedia Page 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;,  Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mmaroney/ Maroney Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011!! &#039;&#039;&#039;[[Molecular Playground/CsoR and RcnR]]&#039;&#039;&#039;, Heidi Hu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
Peyton Lab&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/FAK]]&#039;&#039;&#039;, Dannielle Ryman&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
Schnarr Lab &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: NEW FALL 2011!! &#039;&#039;&#039;[[User:Brittany deRonde|Molecular Playground/HIV Tat]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson] &amp;amp; [http://www.chem.umass.edu/~rmweis/weislab/ Weis] Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011 &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto&lt;br /&gt;
:: Best CBI Molecule Jmol scenes 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Congratulations to the prize-winning CBI molecules noted above! These also provide great examples to follow. Another prize for best CBI Molecule page and/or scene will be awarded in summer 2012!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2011: Complete steps 1-4 by 12/1/11, in preparation for the CBI Molecule Workshop.&lt;br /&gt;
&lt;br /&gt;
Choose a molecule that is part of your research project. If someone in your group has already made a page for your research molecule, you can improve on that previous entry. You must leave the previously created page intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. If you are new to Proteopedia, click Help in the navigation box on the left to get started.&lt;br /&gt;
&lt;br /&gt;
2. Make yourself a sandbox page in which you will develop your CBI Molecule scene and description  (Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. See example [[User:Lynmarie K Thompson/Sandbox 1]]). &lt;br /&gt;
&lt;br /&gt;
3. Follow the format of the sample CBI molecule page [[Molecular Playground/Bacterial Chemotaxis Receptors]]. Easiest way to do this is to copy this page (in editing mode), paste it into your sandbox page, keep the first paragraph about CBI molecules, and then edit to describe and display your molecule. Your goal is to make this an interesting, nontechnical description of the molecule. If multiple people in one group work on the same molecule, you can each make different scenes for the same CBI molecule and each describe them on the same proteopedia page. Talk with each other about your plans so you are not duplicating efforts.&lt;br /&gt;
&lt;br /&gt;
4. Add a link to your sandbox page at [[Sandbox_CBI]] (CBI Molecules in Progress).&lt;br /&gt;
&lt;br /&gt;
5. Create an attractive scene for your molecule: use the scene authoring tools in the edit mode to create the view you like, then copy the wiki text into your window.&lt;br /&gt;
&lt;br /&gt;
6. Choose a &amp;quot;green scene&amp;quot; on your Proteopedia page to suggest for display at the Molecular Playground and specify a &amp;quot;banner&amp;quot; which will be projected with the molecule. This should be a short, one-line headline for your scene that includes the name of the molecule and what is important about the scene or the molecule. Remember to design this for the general public, including non-scientists. My example is: &amp;quot;Molecular Playground banner: A bacterial chemotaxis receptor protein used by bacteria to &amp;quot;smell&amp;quot; their environment.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
7. When you are happy with your sandbox page, make yourself a permanent Proteopedia page, which will be editable by others. Enter &amp;quot;Molecular Playground/your molecule&amp;quot; (omit quotes) in the search box, then follow the instructions to create a new page with this title. Copy the content of your sandbox to this new page.&lt;br /&gt;
&lt;br /&gt;
8. When you have finished the final version of your page and scene, edit this CBI Molecules page to add a listing and link for your molecule, following the  examples above, and be sure to mark it as NEW FALL 2011. If you are improving a previously created page, leave the old one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list. When multiple authors contribute to a Molecular Playground page, please indicate your scene with your initials. Please link the lab names to web pages too.&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333704</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333704"/>
		<updated>2011-12-23T21:10:24Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
It&#039;s great to build on a previous entry, but you must leave the earlier one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
Fall 2011: New entries are due 12/16/11. Please append the designation (new Fall 2011) to your new entries. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2010]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy&lt;br /&gt;
:: Best Overall CBI Molecule 2010&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Caspase-6 and neurodegeneration]]&#039;&#039;&#039;, Kevin Buadlart Dagbay&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011&#039;&#039;&#039; [[Molecular Playground/Transferrin]]&#039;&#039;&#039;, Khaja Muneeruddin&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Knapp lab&lt;br /&gt;
 &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin&lt;br /&gt;
:: Best CBI Molecule Proteopedia Page 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;,  Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mmaroney/ Maroney Lab]&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011!! &#039;&#039;&#039;[[Molecular Playground/CsoR and RcnR]]&#039;&#039;&#039;, Heidi Hu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
Peyton Lab&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/FAK]]&#039;&#039;&#039;, Dannielle Ryman&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
Schnarr Lab &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: NEW FALL 2011!! &#039;&#039;&#039;[[Molecular Playground/HIV Tat]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson] &amp;amp; [http://www.chem.umass.edu/~rmweis/weislab/ Weis] Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011 &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto&lt;br /&gt;
:: Best CBI Molecule Jmol scenes 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Congratulations to the prize-winning CBI molecules noted above! These also provide great examples to follow. Another prize for best CBI Molecule page and/or scene will be awarded in summer 2012!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2011: Complete steps 1-4 by 12/1/11, in preparation for the CBI Molecule Workshop.&lt;br /&gt;
&lt;br /&gt;
Choose a molecule that is part of your research project. If someone in your group has already made a page for your research molecule, you can improve on that previous entry. You must leave the previously created page intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. If you are new to Proteopedia, click Help in the navigation box on the left to get started.&lt;br /&gt;
&lt;br /&gt;
2. Make yourself a sandbox page in which you will develop your CBI Molecule scene and description  (Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. See example [[User:Lynmarie K Thompson/Sandbox 1]]). &lt;br /&gt;
&lt;br /&gt;
3. Follow the format of the sample CBI molecule page [[Molecular Playground/Bacterial Chemotaxis Receptors]]. Easiest way to do this is to copy this page (in editing mode), paste it into your sandbox page, keep the first paragraph about CBI molecules, and then edit to describe and display your molecule. Your goal is to make this an interesting, nontechnical description of the molecule. If multiple people in one group work on the same molecule, you can each make different scenes for the same CBI molecule and each describe them on the same proteopedia page. Talk with each other about your plans so you are not duplicating efforts.&lt;br /&gt;
&lt;br /&gt;
4. Add a link to your sandbox page at [[Sandbox_CBI]] (CBI Molecules in Progress).&lt;br /&gt;
&lt;br /&gt;
5. Create an attractive scene for your molecule: use the scene authoring tools in the edit mode to create the view you like, then copy the wiki text into your window.&lt;br /&gt;
&lt;br /&gt;
6. Choose a &amp;quot;green scene&amp;quot; on your Proteopedia page to suggest for display at the Molecular Playground and specify a &amp;quot;banner&amp;quot; which will be projected with the molecule. This should be a short, one-line headline for your scene that includes the name of the molecule and what is important about the scene or the molecule. Remember to design this for the general public, including non-scientists. My example is: &amp;quot;Molecular Playground banner: A bacterial chemotaxis receptor protein used by bacteria to &amp;quot;smell&amp;quot; their environment.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
7. When you are happy with your sandbox page, make yourself a permanent Proteopedia page, which will be editable by others. Enter &amp;quot;Molecular Playground/your molecule&amp;quot; (omit quotes) in the search box, then follow the instructions to create a new page with this title. Copy the content of your sandbox to this new page.&lt;br /&gt;
&lt;br /&gt;
8. When you have finished the final version of your page and scene, edit this CBI Molecules page to add a listing and link for your molecule, following the  examples above, and be sure to mark it as NEW FALL 2011. If you are improving a previously created page, leave the old one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list. When multiple authors contribute to a Molecular Playground page, please indicate your scene with your initials. Please link the lab names to web pages too.&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333703</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333703"/>
		<updated>2011-12-23T21:00:56Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333702</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333702"/>
		<updated>2011-12-23T20:51:40Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Cell Penetrating Peptides&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039;/&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;User:Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333698</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333698"/>
		<updated>2011-12-23T20:12:27Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039;/&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently demonstrated in 1988 that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333225</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333225"/>
		<updated>2011-12-19T20:13:46Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039;/&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333112</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333112"/>
		<updated>2011-12-18T19:31:43Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333111</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333111"/>
		<updated>2011-12-18T19:29:34Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333020</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333020"/>
		<updated>2011-12-17T00:21:58Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
It&#039;s great to build on a previous entry, but you must leave the earlier one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
Fall 2011: New entries are due 12/16/11. Please append the designation (new Fall 2011) to your new entries. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2010]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy&lt;br /&gt;
:: Best Overall CBI Molecule 2010&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Knapp lab&lt;br /&gt;
 &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin&lt;br /&gt;
:: Best CBI Molecule Proteopedia Page 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;,  Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
Peyton Lab&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
Schnarr Lab &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: NEW FALL 2011!! &#039;&#039;&#039;[http://www.proteopedia.com/wiki/index.php/Molecular_Playground/HIV_Tat Molecular Playground/HIV Tat]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson] &amp;amp; [http://www.chem.umass.edu/~rmweis/weislab/ Weis] Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011 &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto&lt;br /&gt;
:: Best CBI Molecule Jmol scenes 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Congratulations to the prize-winning CBI molecules noted above! These also provide great examples to follow. Another prize for best CBI Molecule page and/or scene will be awarded in summer 2012!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2011: Complete steps 1-4 by 12/1/11, in preparation for the CBI Molecule Workshop.&lt;br /&gt;
&lt;br /&gt;
Choose a molecule that is part of your research project. If someone in your group has already made a page for your research molecule, you can improve on that previous entry. You must leave the previously created page intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. If you are new to Proteopedia, click Help in the navigation box on the left to get started.&lt;br /&gt;
&lt;br /&gt;
2. Make yourself a sandbox page in which you will develop your CBI Molecule scene and description  (Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. See example [[User:Lynmarie K Thompson/Sandbox 1]]). &lt;br /&gt;
&lt;br /&gt;
3. Follow the format of the sample CBI molecule page [[Molecular Playground/Bacterial Chemotaxis Receptors]]. Easiest way to do this is to copy this page (in editing mode), paste it into your sandbox page, keep the first paragraph about CBI molecules, and then edit to describe and display your molecule. Your goal is to make this an interesting, nontechnical description of the molecule. If multiple people in one group work on the same molecule, you can each make different scenes for the same CBI molecule and each describe them on the same proteopedia page. Talk with each other about your plans so you are not duplicating efforts.&lt;br /&gt;
&lt;br /&gt;
4. Add a link to your sandbox page at [[Sandbox_CBI]] (CBI Molecules in Progress).&lt;br /&gt;
&lt;br /&gt;
5. Create an attractive scene for your molecule: use the scene authoring tools in the edit mode to create the view you like, then copy the wiki text into your window.&lt;br /&gt;
&lt;br /&gt;
6. Choose a &amp;quot;green scene&amp;quot; on your Proteopedia page to suggest for display at the Molecular Playground and specify a &amp;quot;banner&amp;quot; which will be projected with the molecule. This should be a short, one-line headline for your scene that includes the name of the molecule and what is important about the scene or the molecule. Remember to design this for the general public, including non-scientists. My example is: &amp;quot;Molecular Playground banner: A bacterial chemotaxis receptor protein used by bacteria to &amp;quot;smell&amp;quot; their environment.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
7. When you are happy with your sandbox page, make yourself a permanent Proteopedia page, which will be editable by others. Enter &amp;quot;Molecular Playground/your molecule&amp;quot; (omit quotes) in the search box, then follow the instructions to create a new page with this title. Copy the content of your sandbox to this new page.&lt;br /&gt;
&lt;br /&gt;
8. When you have finished the final version of your page and scene, edit this CBI Molecules page to add a listing and link for your molecule, following the  examples above, and be sure to mark it as NEW FALL 2011. If you are improving a previously created page, leave the old one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list. When multiple authors contribute to a Molecular Playground page, please indicate your scene with your initials. Please link the lab names to web pages too.&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333019</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=1333019"/>
		<updated>2011-12-17T00:21:16Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
It&#039;s great to build on a previous entry, but you must leave the earlier one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
Fall 2011: New entries are due 12/16/11. Please append the designation (new Fall 2011) to your new entries. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2010]]&#039;&#039;&#039;, Joe White, David Griffin&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy&lt;br /&gt;
:: Best Overall CBI Molecule 2010&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Knapp lab&lt;br /&gt;
 &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin&lt;br /&gt;
:: Best CBI Molecule Proteopedia Page 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;,  Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &lt;br /&gt;
:: Best CBI Molecule 2011&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
&lt;br /&gt;
: NEW Fall 2011! &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
Peyton Lab&lt;br /&gt;
: NEW FALL 2011! &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
Schnarr Lab &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: NEW FALL 2011!! &#039;&#039;&#039;[http://www.proteopedia.com/wiki/index.php/Molecular_Playground/HIV_Tat Playground/HIV Tat]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson] &amp;amp; [http://www.chem.umass.edu/~rmweis/weislab/ Weis] Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang&lt;br /&gt;
&lt;br /&gt;
: New Fall 2011 &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto&lt;br /&gt;
:: Best CBI Molecule Jmol scenes 2010&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Congratulations to the prize-winning CBI molecules noted above! These also provide great examples to follow. Another prize for best CBI Molecule page and/or scene will be awarded in summer 2012!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2011: Complete steps 1-4 by 12/1/11, in preparation for the CBI Molecule Workshop.&lt;br /&gt;
&lt;br /&gt;
Choose a molecule that is part of your research project. If someone in your group has already made a page for your research molecule, you can improve on that previous entry. You must leave the previously created page intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. If you are new to Proteopedia, click Help in the navigation box on the left to get started.&lt;br /&gt;
&lt;br /&gt;
2. Make yourself a sandbox page in which you will develop your CBI Molecule scene and description  (Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. See example [[User:Lynmarie K Thompson/Sandbox 1]]). &lt;br /&gt;
&lt;br /&gt;
3. Follow the format of the sample CBI molecule page [[Molecular Playground/Bacterial Chemotaxis Receptors]]. Easiest way to do this is to copy this page (in editing mode), paste it into your sandbox page, keep the first paragraph about CBI molecules, and then edit to describe and display your molecule. Your goal is to make this an interesting, nontechnical description of the molecule. If multiple people in one group work on the same molecule, you can each make different scenes for the same CBI molecule and each describe them on the same proteopedia page. Talk with each other about your plans so you are not duplicating efforts.&lt;br /&gt;
&lt;br /&gt;
4. Add a link to your sandbox page at [[Sandbox_CBI]] (CBI Molecules in Progress).&lt;br /&gt;
&lt;br /&gt;
5. Create an attractive scene for your molecule: use the scene authoring tools in the edit mode to create the view you like, then copy the wiki text into your window.&lt;br /&gt;
&lt;br /&gt;
6. Choose a &amp;quot;green scene&amp;quot; on your Proteopedia page to suggest for display at the Molecular Playground and specify a &amp;quot;banner&amp;quot; which will be projected with the molecule. This should be a short, one-line headline for your scene that includes the name of the molecule and what is important about the scene or the molecule. Remember to design this for the general public, including non-scientists. My example is: &amp;quot;Molecular Playground banner: A bacterial chemotaxis receptor protein used by bacteria to &amp;quot;smell&amp;quot; their environment.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
7. When you are happy with your sandbox page, make yourself a permanent Proteopedia page, which will be editable by others. Enter &amp;quot;Molecular Playground/your molecule&amp;quot; (omit quotes) in the search box, then follow the instructions to create a new page with this title. Copy the content of your sandbox to this new page.&lt;br /&gt;
&lt;br /&gt;
8. When you have finished the final version of your page and scene, edit this CBI Molecules page to add a listing and link for your molecule, following the  examples above, and be sure to mark it as NEW FALL 2011. If you are improving a previously created page, leave the old one intact and make a copy that you improve and mark as new.  Later we will retain the new one with a merged author list. When multiple authors contribute to a Molecular Playground page, please indicate your scene with your initials. Please link the lab names to web pages too.&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333018</id>
		<title>Molecular Playground/HIV Tat</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/HIV_Tat&amp;diff=1333018"/>
		<updated>2011-12-17T00:16:41Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: New page: One of the CBI Molecules being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at th...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333017</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333017"/>
		<updated>2011-12-17T00:14:30Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Grey residues = polar groups, Pink residues= hydrophobic residues, and Blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333016</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333016"/>
		<updated>2011-12-17T00:13:33Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Introduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;HIV Tat. Pink residues = polar groups, grey residues= hydrophobic residues, and blue residues= protein transduction domain&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333015</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333015"/>
		<updated>2011-12-17T00:11:22Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Acknowledgments&#039;&#039;&#039; ==&lt;br /&gt;
The Tew research group is gratefully acknowledged for their contributions to the design and content of this page. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333014</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333014"/>
		<updated>2011-12-17T00:08:33Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;My Research Interests&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers (as shown below), ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  Hydrophobicity, charge, aromaticity, and pi-electronics of the monomer structures can be optimized to achieve better cellular uptake and cell viability by changing R1 and R2.&lt;br /&gt;
&lt;br /&gt;
[[Image:norbornenederivatives.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Norbornenederivatives.png&amp;diff=1333013</id>
		<title>File:Norbornenederivatives.png</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Norbornenederivatives.png&amp;diff=1333013"/>
		<updated>2011-12-17T00:04:39Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333012</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333012"/>
		<updated>2011-12-16T23:59:20Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interests&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers, ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  By tuning the functionalization of the monomer structures and the resulting CPP molecular weights, cellular uptake and cell viability can be optimized.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333011</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333011"/>
		<updated>2011-12-16T23:56:39Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* Endocytosis */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
Another proposed mechanism for cellular uptake is endocytosis, specifically macropinocytosis.  This form of fluid phase endocytosis is less known that other types (phagocytosis, clathrin, and coated pit), it is believed to occur in all cell types and enable the uptake of large molecules.  &amp;lt;ref&amp;gt;Gump &#039;&#039;et al. Trends in Molecular Medicine.&#039;&#039; &#039;&#039;&#039;2007&#039;&#039;&#039;. 13, 443-448.&amp;lt;/ref&amp;gt;  During this process, actin protrusions fold around molecules and the surrounding medium and enable cellular uptake.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Drug Delivery Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
XXXXXX&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interest&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers, ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  By tuning the functionalization of the monomer structures and the resulting CPP molecular weights, cellular uptake and cell viability can be optimized.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333008</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1333008"/>
		<updated>2011-12-16T23:33:44Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* Transduction */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm. &amp;lt;ref&amp;gt;Richard &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 585-590.&amp;lt;/ref&amp;gt;  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways.&amp;lt;ref&amp;gt;Drin &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 276, 31192-31201.&amp;lt;/ref&amp;gt;  Some groups have also studied transduction of Tat using model vesicles. &amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 278, 9185-9194.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Drug Delivery Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
XXXXXX&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interest&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers, ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  By tuning the functionalization of the monomer structures and the resulting CPP molecular weights, cellular uptake and cell viability can be optimized.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1332999</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1332999"/>
		<updated>2011-12-16T23:09:47Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* Transduction */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membranes.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values. Fixed cells showed higher concentrations of Tat in nuclei compared to non-fixed cells where it was localized in the cytoplasm.  Studies also showed that FACS could not tell the difference between internalized cells and those proteins that were only bound to the cellular membranes. Cellular uptake studies performed at 4°C and under conditions of ATP depletion show that a small percentage of CPPs can enter cells and also suggests that a majority of the protein enters cells through energy dependent pathways. Some groups have also studied transduction of Tat using model vesicles.&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Drug Delivery Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
XXXXXX&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interest&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers, ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  By tuning the functionalization of the monomer structures and the resulting CPP molecular weights, cellular uptake and cell viability can be optimized.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1332982</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1332982"/>
		<updated>2011-12-16T21:56:27Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* &amp;#039;&amp;#039;&amp;#039;Tat-mediated Transduction&amp;#039;&amp;#039;&amp;#039; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  The exact mechanism of cellular uptake is still highly debated in the literature, but a couple of the proposed methods are discussed below.&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membrane.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values.&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Drug Delivery Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
XXXXXX&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interest&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers, ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  By tuning the functionalization of the monomer structures and the resulting CPP molecular weights, cellular uptake and cell viability can be optimized.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1332981</id>
		<title>Brittany deRonde/Sandbox 1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Brittany_deRonde/Sandbox_1&amp;diff=1332981"/>
		<updated>2011-12-16T21:47:06Z</updated>

		<summary type="html">&lt;p&gt;Brittany deRonde: /* Transduction */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;One of the [[CBI Molecules]] being studied in the  [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Introduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;HIV Tat&#039;&#039;&#039;, or simply Tat, is a human immunodeficiency virus (HIV) gene that regulates transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 227, 171-173. [http://www.jstor.org/stable/1695050] http://www.jstor.org/stable/1695050&amp;lt;/ref&amp;gt;  Tat, which stands for trans-activator of transcription, contains 86 amino acid residues in its sequence.&amp;lt;ref&amp;gt;Arya &#039;&#039;et al. Science&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 69-73.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Sodroski &#039;&#039;et al. Science.&#039;&#039; &#039;&#039;&#039;1985&#039;&#039;&#039;. 229, 74-77.&amp;lt;/ref&amp;gt; &amp;lt;Structure load=&#039;1TIV&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/2&#039; /&amp;gt; It is released by HIV infected cells in order to enhance replication of the virus.&amp;lt;ref&amp;gt;Dayton &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 44, 941-947.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Fisher &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1986&#039;&#039;&#039;. 320, 367-371.&amp;lt;/ref&amp;gt;  Nanomolar concentrations of Tat have been reported in the blood of HIV-1 infected people.&amp;lt;ref&amp;gt;Xiao &#039;&#039;et al. Proc. Natl. Acad. Sci. USA.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 11466-11471.&amp;lt;/ref&amp;gt; When the protein enters non-infected cells, the transcription efficiency increases.  It is estimated that transcription levels are 10 to 100 fold higher during the transcription elongation stage when compared to normal basal transcription.&amp;lt;ref&amp;gt;Ensoli &#039;&#039;et al. Nature.&#039;&#039; &#039;&#039;&#039;1990&#039;&#039;&#039;. 345, 84-86.&amp;lt;/ref&amp;gt;  Green and Lowenstein, and Frankel and Pabo independently published studies in 1988 that demonstrated that Tat had the ability to cross cellular membranes and initiate transcription of HIV dsRNA.&amp;lt;ref&amp;gt;Green &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1179-1188.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Frankel &#039;&#039;et al. Cell.&#039;&#039; &#039;&#039;&#039;1988&#039;&#039;&#039;. 55, 1189-1193.&amp;lt;/ref&amp;gt;  These were the first known reports of a &#039;&#039;&#039;cell penetrating peptide (CPP)&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Cell Penetrating Peptides&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Cell penetrating peptides (CPPs)&#039;&#039;&#039; are proteins with the ability to cross cellular membranes and facilitate the uptake of various cargo, such as small molecules, siRNA, and small DNA fragments.&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;  Such cargo can be associated via covalent or non-covalent interactions.  Tat is considered a CPP because it contains a protein transduction domain (PTD).  PTDs are cation-rich sequences of 10-30 residues, usually containing several Lysine and/or Arginine residues.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 452-472.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine1.jpg]] [[Image:Lysine1.jpg]]&lt;br /&gt;
&lt;br /&gt;
These sequences improve interactions between CPPs and cellular membranes and can help them enter cells.  The PTD sequence in Tat is YGRKKRRQRRR (amino acid &amp;lt;scene name=&#039;Brittany_deRonde/Sandbox_1/Hiv_tat/3&#039;&amp;gt;residues 47-57&amp;lt;/scene&amp;gt;), which is Arginine-rich. This 11 amino-acid sequence is now referred to as the TAT peptide, and has be shown to have improved cellular uptake compared to Tat.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Since the discovery of HIV Tat, other Arginine-rich, natural CPPs have been discovered including, penetratin from Drosophila antennapedia protein, sweet arrow peptide (SAP), HIV-1 Rev, flock house virus (FHV) coat, brome mosaic virus (BMV) Gag, human T-cell lymphotrophic virus (HTLV)-II Rex, and the nuclear localization signal (NLS) from nucleoplasmin. &amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Prochiantz &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 448-451.&amp;lt;/ref&amp;gt; The PTD sequences for these proteins can be found in the table below. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Arginine_Rich_Peptides.png]]&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Tat-mediated Transduction&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The PTD in HIV Tat is highly cationic.  When charged residues (Arginine or Lysine) are replaced with neutral residues (Alanine), cellular uptake decreases.  It is likely that the cationic charge is necessary for electrostatic interactions with components of the cellular membrane, such as lipid head groups and proteoglycans.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Biochemistry&#039;&#039; &#039;&#039;&#039;2003&#039;&#039;&#039;. 42, 9185-9194.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Goncalves &#039;&#039;et al. Biochemistry.&#039;&#039; &#039;&#039;&#039;2005&#039;&#039;&#039;. 44, 2692-2702.&amp;lt;/ref&amp;gt;  Other interactions may also play a role in interactions with the cellular membrane, such as hydrophobic and non-covalent interactions.&amp;lt;ref&amp;gt;Ziegler &#039;&#039;et al. Adv. Drug Deliv. Rev.&#039;&#039; &#039;&#039;&#039;2008&#039;&#039;&#039;. 60, 580-597.&amp;lt;/ref&amp;gt;  Although cellular uptake is not directly dependent upon architecture (branched vs. linear), it is dependent upon the number of Arginine residues. Polymers with less than five arginine residues are unable to enter cells.&amp;lt;ref&amp;gt;Wender &#039;&#039;et al. Proc. Natl. Acad. Sci.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 97, 13003-13008.&amp;lt;/ref&amp;gt;  As the number of residues increases, cellular uptake improves up until 15 residues where polymers can enter cells but with hindered efficiencies.&amp;lt;ref&amp;gt;Mitchell &#039;&#039;et al. J. Pept. Res.&#039;&#039; &#039;&#039;&#039;2000&#039;&#039;&#039;. 56, 318-325.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Futaki &#039;&#039;et al. J. Biol. Chem.&#039;&#039; &#039;&#039;&#039;2001&#039;&#039;&#039;. 276, 5836-5840.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Transduction==&lt;br /&gt;
Early studies indicated that HIV Tat primarily entered cells through transduction, meaning that the protein directly crossed the cell membrane.  However, for most of these studies, cells were fixed with formaldehyde prior to sample analysis.  In 2003, it was discovered that by fixing cells prior to analysis, it permeablized the cell membranes and resulted in artificially high cellular uptake values.&lt;br /&gt;
&lt;br /&gt;
==Endocytosis==&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Drug Delivery Applications&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
XXXXXX&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;My Research Interest&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
As part of the [http://www.pse.umass.edu/gtew/index.html Tew Research Group] in the [http://www.pse.umass.edu Department of Polymer Science and Engineering] at the University of Massachusetts, Amherst, I am interested in the design of Tat-inspired CPPs for drug and gene delivery.  Using functionalized oxanorbornene derivatives as monomers, ring opening metathesis polymerization (ROMP) is performed using Grubbs&#039; 3rd generation catalyst to synthesize cationic CPP mimics.  By tuning the functionalization of the monomer structures and the resulting CPP molecular weights, cellular uptake and cell viability can be optimized.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;References&#039;&#039;&#039; ==&lt;br /&gt;
{{Reflist}}&lt;/div&gt;</summary>
		<author><name>Brittany deRonde</name></author>
	</entry>
</feed>